4-Methylmorpholine → 5-methyl-2-(4-piperidinyl)-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one

HRID 1162285노트

반응식

HRID 1162285 반응식
ClC1[CH:7]=[CH:6][C:5]([NH:8][C:9](=[O:22])[NH:10][CH:11]([CH2:15]C2C=CC=CC=2)[C:12](O)=O)=[CH:4][CH:3]=1.C1C=C[C:26]2N(O)N=[N:29][C:27]=2C=1.CC[N:35]=C=NCCCN(C)C.CN1CCOCC1>CN(C=O)C>[CH3:26][C:27]1[N:10]2[C:9](=[O:22])[N:8]([CH:5]3[CH2:4][CH2:3][NH:35][CH2:7][CH2:6]3)[CH2:12][C:11]2=[CH:15][N:29]=1

참가 물질

6

반응물 4

HCID 79724-MethylmorpholineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 757711-HydroxybenzotriazoleHCID 29747892-(N'-(4-chlorophenyl)ureido)-3-phenylpropanoic acid

생성물 1

HCID 230840155-methyl-2-(4-piperidinyl)-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one수율 99.5%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

To a solution of 2-(N′-(4-chlorophenyl)ureido)-3-phenylpropanoic acid (0.16 g) obtained in Example 1b) and HOBt (0.12 g) in DMF (10 ml) was added WSC (0.14 g), and the reaction mixture was mixed at room temperature for 15 minutes. Then, 5-methyl-2-(4-piperidinyl)-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one (0.11 g) obtained in Reference Example 1 and N-methylmorpholine (0.08 ml) were added thereto. The reaction mixture was mixed at room temperature for 15 hours, and then the solvent was distilled off under reduced pressure. The residue was dissolved in ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the residue was purified with silica gel column (ethyl acetate to ethyl acetate/methanol=10/1). The product was washed with diethyl ether to obtain the title compound as colorless powder (0.13 g, 50%).

후처리

  1. additionthe reaction mixture was mixed at room temperature for 15 minutes

출처 및 근거

ORD 기록
ord-ecf8ae63a38846658d2af4150219f67d
출처 데이터셋
uspto-grants-2010_10
특허 번호
US07820673B2

반응 노트

불러오는 중…